securities fraud

Schall Law Firm seeks investors in $ODDITY securities fraud class action over allegedly false statements regarding customer acquisition costs and ad partner algorithm changes.

FTC lawsuit alleges Zillow and Redfin unlawfully suppressed rental advertising competition. $Z stock fell 4.6% on October 1, 2025.

Rosen Law Firm filed class action against $GLOB over alleged misrepresentations regarding its $1B Latin American pivot. Lead plaintiff deadline set for June 23, 2026.

Rosen Law Firm files class actions against $RGC, $GLOB, $NKTR alleging false statements. Investors have until June 23, 2026 to become lead plaintiffs.

DNOW stock crashed 19.1% after Q4 2025 earnings miss. The Rosen Law Firm investigates potential securities fraud; investors invited to join class action lawsuit.

ADMA Biologics stock plunged 16.6% after short seller allegations of channel stuffing. Law firm investigates potential securities fraud claims.

Securities investigators examine allegations that LKQ, Molina Healthcare, Power Solutions, and Varonis misled investors on business performance and financial guidance through fiduciary breaches.

Class action lawsuit filed against POET Technologies alleging securities fraud, misrepresentation of tax status, and officer's NDA violation affecting April 2026 investors.

Class action lawsuit filed against $IBRX alleging securities fraud over false statements regarding Anktiva capabilities. Investors who purchased shares January-March 2026 may be eligible.

Class action filed against Regencell Bioscience for allegedly false statements on operations and market manipulation vulnerabilities affecting investors during October 2024-October 2025 period.

Class action filed against $EOSE alleging securities fraud over undisclosed production delays, quality control failures, and inaccurate guidance from November 2025 to February 2026.

Class action lawsuit filed against $MNDY alleging materially false statements about revenue outlook and sales cycles from September 2025 to February 2026.

Class action lawsuit filed against Boston Scientific alleging materially false statements about U.S. electrophysiology segment growth. Investors who purchased BSX shares July 2025-February 2026 eligible.

Class action lawsuit filed against $COTY alleging executives made false statements about growth prospects during November 2025-February 2026 period.

Class action lawsuit filed against Aldeyra Therapeutics alleging false statements regarding reproxalap clinical trial results. Investors from Nov 2023-Mar 2026 may be eligible.

Trip.com faces class action alleging inadequate disclosure of monopoly-related regulatory risks. Investors harmed from April 2024 to January 2026 can join the lawsuit by May 11, 2026.

Class action lawsuit filed against Alight ($ALIT) alleging executives made false statements about CEO transition, capital returns, and revenue growth between November 2024 and February 2026.

Law firms file class action against Activision, alleging executives made false statements about Microsoft acquisition and concealed workplace harassment during deal negotiations.

Rosen Law Firm investigates $SRAD following Muddy Waters report alleging illegal gambling ties. Stock plunged 22.6% on compliance concerns.

Robbins LLP files class action against Babcock & Wilcox ($BW) over alleged investor deception regarding shareholder relationships and contract legitimacy, exposing alleged disclosure failures from November 2025-March 2026.